EDITOR : Zhang Yongxin


Zyxell Inc



Dr. Zhang is the CEO at Zyxell Inc undertaking the Research and development of bioreactors, Research on cancer immune evasion and immunotherapy; anticancer drug evaluation; stem cell and immunocyte expansion; molecular mechanism of the tissue construction, and the “self-renewal” maintenance of expanding stem cells; clinical application (clinical trials) of expanded hematopoietic stem cells, cancer vaccine, and fast immunoassays.

research interest

  • Immunology, including vaccine development and evaluation
  • Stem cell technology
  • Cancer biology
  • Infectious diseases
  • Aging
  • Liver diseases
  • Molecular biology
  • Cellular Biology

Support Links

Track Your Article

Twitter Tweets